Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2021

Jan 5, 2021

32641_dirs_2021-01-04_0999994c-9103-46bf-8dfb-8693631ed2e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2020-12-31

Reporting Person: SPENCER JOHN N JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-31 Common Stock A 208 $15.00 Acquired 24042 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 187 Indirect

Footnotes

F1: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $15.00 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2020.

F2: Includes 22,900 shares held jointly with spouse and 510 shares held in an IRA.